Bridge Bank today announced that its Boston-based Technology Banking Group has issued a venture debt term loan of $6 million to Mixlab, the modern pet pharmacy that partners with veterinarians to deliver the highest level of care at home.
Mixlab will use the funding to further its revenue growth by enhancing its technology offering, scaling sales and marketing efforts and expanding to provide same-day delivery across new geographies.
“Supporting the team at Mixlab as they work to extend their reach and achieve their growth goals is extremely rewarding,” said Darren Gastrock, director in Bridge Bank’s Boston-based Technology Banking Group.
“We are geared to helping innovative clients across the country, like Mixlab, meet their ambitions,” added Roger Klarmann, senior director in Bridge Bank’s Technology Banking Group.
Bridge Bank earned the capital financing relationship through a competitive bid process led by debt financing adviser Cafferty & Company, which served as an independent adviser to Mixlab on the transaction.
